Trilateral '3P' mechanics of stabilized layersomes technology for efficient oral immunization

Journal of Biomedical Nanotechnology

Volumn 11, Issue 3, 2015, Pages 363-381

  Harde, Harshad ^a   Agrawal, Ashish Kumar ^a   Jain, Sanyog ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Box behnken; Immune response; Macrophage uptake; Stability; Stable liposomes; Vaccines

Indexed keywords

ANTIGENS; BODY FLUIDS; COATINGS; CONVERGENCE OF NUMERICAL METHODS; IMMUNIZATION; LIPOSOMES; MULTILAYERS; POLYELECTROLYTES; STABILITY; VACCINES;

ANTIGEN PRESENTING CELLS; BOVINE SERUM ALBUMINS; BOX-BEHNKEN; CONFORMATIONAL STABILITIES; EXPLANATORY VARIABLES; IMMUNE RESPONSE; LONG-TERM STORAGE STABILITY; POLYALLYLAMINE HYDROCHLORIDE;

IMMUNE SYSTEM;

ANTIGEN; BOVINE SERUM ALBUMIN; CHLORIDE; CRYOPROTECTIVE AGENT; LIPOSOME; POLYACRYLIC ACID; POLYELECTROLYTE; TREHALOSE; BIOMATERIAL; EXCIPIENT; NANOCAPSULE; NANOCONJUGATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXPLANATORY VARIABLE; FILM; HYDRATION; IMMUNIZATION; MECHANICS; MOUSE; NONHUMAN; SPECTROFLUOROMETRY; ANIMAL; CELL CULTURE; CHEMICAL MODEL; CHEMISTRY; COMPUTER SIMULATION; DIFFUSION; DRUG DESIGN; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; SYNTHESIS; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; COMPUTER SIMULATION; DIFFUSION; DRUG DESIGN; EXCIPIENTS; IMMUNIZATION; LIPOSOMES; MACROPHAGES; MICE; MODELS, CHEMICAL; NANOCAPSULES; NANOCONJUGATES; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; TREHALOSE;

EID: 84918576969     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2015.1913     Document Type: Article

References (49)

1. V. P. Torchilin, Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov. 4, 145 (2005).
2. D. Papahadjopoulos, T. Allen, A. Gabizon, E. Mayhew, K. Matthay, S. Huang, K. Lee, M. Woodle, D. Lasic, and C. Redemann, Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad Sci. 88, 11460 (1991).
3. G. Gregoriadis, B. McCormack, M. Obrenovic, R. Saffie, B. Zadi, and Y. Perrie, Vaccine entrapment in liposomes. Methods 19, 156 (1999).
4. T. Lian and R. J. Y. Ho, Trends and developments in liposome drug delivery systems. J. Pharm. Sci. 90, 667 (2001).
5. H. Chen, V. Torchilin, and R. Langer, Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability. J. Control Release 42, 263 (1996).
6. H. Chen, V. Torchilin, and R. Langer, Lectin-bearing polymerized liposomes as potential oral vaccine carriers. Pharm. Res. 13, 1378 (1996).
7. N. Venkatesan and S. P. Vyas, Polysaccharide coated liposomes for oral immunization-development and characterization. Int. J. Pharm. 203, 169 (2000).
8. S. Jain, D. Kumar, N. K. Swarnakar, and K. Thanki, Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33, 6758 (2012).
9. P. Jain, S. Jain, K. N. Prasad, S. K. Jain, and S. P. Vyas, Polyelectrolyte coated multilayered liposomes (nanocapsules) for the treatment of Helicobacter pylori infection. Mol. Pharmaceutics 6, 593 (2009).
10. A. K. Agrawal, H. P. Harde, K. Thanki, and S. Jain, Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration. Biomacromolecules 15, 350 (2014).
11. S. Jain, S. R. Patil, N. K. Swarnakar, and A. K. Agrawal, Oral delivery of doxorubicin using novel polyelectrolytes stabilized liposomes (Layersomes). Mol. Pharmaceutics 9, 2626 (2012).
12. E. L. Giudice and J. D. Campbell, Needle-free vaccine delivery. Adv. Drug Del. Rev. 58, 68 (2006).
13. M. C. Morris, J. Depollier, J. Mery, F. Heitz, and G. Divita, A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19, 1173 (2001).
14. S. Jain, A. Indulkar, H. Harde, and A. K. Agrawal, Oral mucosal immunization using glucomannosylated bilosomes. J. Biomed. Nanotechnol. 10, 932 (2014).
15. B. Malik, A. K. Goyal, F. Zakir, and S. P. Vyas, Surface engineered nanoparticles for oral immunization. J. Biomed. Nanotechnol. 7, 132 (2011).
16. S. Jain, H. Harde, A. Indulkar, and A. K. Agrawal, Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine NBM 10, 431 (2014).
17. J. Holmgren and C. Czerkinsky, Mucosal immunity and vaccines. Nat. Med. 11, S45 (2005).
18. Z. Rahman, A. S. Zidan, and M. A. Khan, Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur. J. Pharm Biopharm. 76, 127 (2010).
19. J. Hao, X. Fang, Y. Zhou, J. Wang, F. Guo, F. Li, and X. Peng, Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int. J. Nanomed. 6, 683 (2011).
20. S. Jain, V. V. Rathi, A. K. Jain, M. Das, and C. Godugu, Folatedecorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine 7, 1311 (2012).
21. M. Jelvehgari, P. Zakeri-Milani, M. R. Siahi-Shadbad, B. D. Loveymi, A. Nokhodchi, Z. Azari, and H. Valizadeh, Development of pH-sensitive insulin nanoparticles using eudragit l100-55 and chitosan with different molecular weights. AAPS PharmSciTech. 11, 1237 (2010).
22. B. Sarmento, D. C. Ferreira, L. Jorgensen, and M. Van De Weert, Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles. Eur. J. Pharm. Biopharm. 65, 10 (2007).
23. E. Roger, F. Lagarce, and J. P. Benoit, The gastrointestinal stability of lipid nanocapsules. Int. J. Pharm. 379, 260 (2009).
24. A. Shukla, O. P. Katare, B. Singh, and S. P. Vyas, M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int. J. Pharm. 385, 47 (2010).
25. P. N. Wiecinski, K. M. Metz, A. N. Mangham, K. H. Jacobson, R. J. Harriers, and J. A. Pedersen, Gastrointestinal biodurability of engineered nanoparticles: Development of an in vitro assay. Nanotoxicology 3, 202 (2009).
26. Y. P. Li, Y. Y. Pei, X. Y. Zhang, Z. H. Gu, Z. H. Zhou, W. F. Yuan, J. J. Zhou, J. H. Zhu, and X. J. Gao, PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J. Control Release 71, 203 (2001).
27. X. Shan, C. Liu, Y. Yuan, F. Xu, X. Tao, Y. Sheng, and H. Zhou, In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf B 72, 303 (2009).
28. A. K. Jain, N. K. Swarnakar, C. Godugu, R. P. Singh, and S. Jain, The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials 32, 503 (2011).
29. P. Ojer, L. Neutsch, F. Gabor, J. M. Irache, A. L. de Cerain, and pez, Cytotoxicity and cell interaction studies of bioadhesive poly(anhydride) nanoparticles for oral antigen/drug delivery. J. Biomed. Nanotechnol. 9, 1891 (2013).
30. S. McClean, E. Prosser, E. Meehan, D. O'Malley, N. Clarke, Z. Ramtoola, and D. Brayden, Binding and uptake of biodegradable poly-DL-lactide micro-And nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6, 153 (1998).
31. J. M. Gamboa and K. W. Leong, In vitro and in vivo models for the study of oral delivery of nanoparticles. Adv. Drug Del. Rev. 65, 800 (2013).
32. S. Jain, P. Singh, V. Mishra, and S. Vyas, Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against Hepatitis B. Immunol Lett. 101, 41 (2005).
33. A. Vila, A. Sanchez, K. Janes, I. Behrens, T. Kissel, J. L. V. Jato, and M. J. Alonso, Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 57, 123 (2004).
34. F. Sarti, G. Perera, F. Hintzen, K. Kotti, V. Karageorgiou, O. Kammona, C. Kiparissides, and A. Bernkop-Schnurch, In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials 32, 4052 (2011).
35. A. Shrivastava, S. Sakthivel, B. Pitchumani, and A. Rathore, A statistical approach for estimation of significant variables in wet attrition milling. Powder Technol. 211, 46 (2011).
36. Y. Zhang, M. Huo, J. Zhou, A. Zou, W. Li, C. Yao, and S. Xie, DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 12, 263 (2010).
37. D. Y. Arifin, L. Y. Lee, and C. H. Wang, Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems. Adv. Drug Deliv. Rev. 58, 1274 (2006).
38. H. Harde, R. P. Singh, A. K. Agrawal, and S. Jain, Disease-based selection of nanocarriers in drug delivery based on hydrophobicity and surface charge. J. Nanogen. Nanomed. 1, 1 (2013).
39. T. J. McIntosh and S. A. Simon, Roles of bilayer material properties in function and distribution of membrane proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 177 (2006).
40. S. Raffy and J. Teissie, Control of lipid membrane stability by cholesterol content. Biophys. J. 76, 2072 (1999).
41. D. Persson, P. E. Thorén, E. K. Esbjörner, M. Goksör, P. Lincoln, and B. Nordén, Vesicle size-dependent translocation of penetratin analogs across lipid membranes. BBA-Biomembranes 1665, 142 (2004).
42. A. Aderem and R. J. Ulevitch, Toll-like receptors in the induction of the innate immune response. Nature 406, 782 (2000).
43. F. Niedergang and M.-N. Kweon, New trends in antigen uptake in the gut mucosa. Trends Microbiol. 13, 485 (2005).
44. E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chickering, P. Chaturvedi, C. A. Santos, K. Vijayaraghavan, S. Montgomery and M. Bassett, Biologically erodable microspheres as potential oral drug delivery systems. Nature 386, 410 (1997).
45. H. Harde, M. Das, and S. Jain, Solid lipid nanoparticles: An oral bioavailability enhancer vehicle. Exp. Opin. Drug. Del. 8, 1407 (2011).
46. A. Des Rieux, V. Fievez, M. Garinot, Y. J. Schneider, and V. Préat, Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Control Release 116, 1 (2006).
47. P. J. Tacken, I. J. M. de Vries, R. Torensma, and C. G. Figdor, Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7, 790 (2007).
48. P. L. Ogra, H. Faden, and R. C. Welliver, Vaccination strategies for mucosal immune responses. Clin. Microb. Rev. 14, 430 (2001).
49. I. R. Mackay, F. S. Rosen, and G. Ada, Vaccines and vaccination. N. Engl. J. Med. 345, 1042 (2001).